BC
Broadwood Capital Portfolio holdings
AUM
$1.53B
This Quarter Return
+34.66%
1 Year Return
+36.91%
3 Year Return
+67.63%
5 Year Return
+132.65%
10 Year Return
+697.91%
AUM
$1.68B
AUM Growth
+$1.68B
(+32%)
Cap. Flow
-$16.7M
Cap. Flow
% of AUM
-1%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
iShares Russell 2000 ETF
IWM
|
$16.7M |
Sector Composition
| 1 | Healthcare | 56.95% |
| 2 | Consumer Staples | 25.69% |
| 3 | Industrials | 5.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
STAAR Surgical
STAA
$1.36B
| $855M | 50.73% | 10,795,348 | – | – |
|
2
Monster Beverage
MNST
$60.9B
| $431M | 25.55% | 4,656,488 | – | – |
|
|
3
iShares Russell 2000 ETF
IWM
$67B
| $198M | 11.74% | 1,009,700 -85,300 | -8% | -$16.7M |
|
4
Axon Enterprise
AXON
$58.7B
| $93.1M | 5.52% | 760,062 | – | – |
|
5
Lineage Cell Therapeutics
LCTX
$267M
| $59.8M | 3.55% | 34,005,379 | – | – |
|
|
IMDX
6
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$72.4M
| $35.2M | 2.09% | 14,716,204 | – | – |
|
7
Serina Therapeutics
SER
$54.5M
| $4.56M | 0.27% | 2,997,156 | – | – |
|